Related Articles
Biological and pharmacological characterisation of three models of human ovarian carcinoma established in nude mice: use of the CA125 tumour marker to predict antitumour activity.
COMPARISON OF CYTOTOXICITY AND CELL KINETIC PERTURBATIONS OF 5 PLATINUM COMPOUNDS IN GYNECOLOGIC CANCER CELL-LINES
PRMT1 expression predicts sensitivity to platinum‑based chemotherapy in patients with ovarian serous carcinoma
Inhibition of pre-mRNA splicing by cisplatin and platinum analogs
Enhanced therapeutic effect of amsalog (CI-921) in combination with cisplatin in vitro and in vivo